Katrina Azer, a clinical pharmacist for Tend Health, looks at reasons why patients don’t take their medicines correctly and how health professionals can address it
Consultant cardiologist Chris Ellis discusses the recent funding of rosuvastatin, focusing on its use for secondary prevention of cardiovascular disease
Biological medicines have markedly changed the prognoses for many chronic and disabling inflammatory and immunological conditions and cancers. Their use in New Zealand is increasing and, as patents expire on reference or originator “biologics”, the opportunity arises for competitor manufacturers to list biosimilars – highly similar versions of approved biological medicines
For the last decade, Martin Woodbridge has worked with regulators, and industry and health professionals to promote the rational use of cannabis-based medicines. Here, he considers the introduction of cannabis-based medicines to New Zealand and explores what it means for pharmacy practice
Linda Bryant discusses gout, a chronic long-term condition that is often associated with other diseases, and drug-related morbidity and mortality. As such, gout needs to be addressed holistically as part of the psychosocial medical model
Professor Ngaire Kerse says new medicines for heart failure have appeared in recent years. With optimised use, these support the main goal of treatment, which is periods of stability with good quality of life
Christchurch pharmacist Sarah Mooney says pharmacists and pharmacy staff are not off the hook when it comes to realising the seriousness of coeliac disease, as commonly dispensed medications and over-the-counter products may contain gluten
This article, by Alex Bartle, a former GP and Auckland-based director of Sleep Well Clinic, reviews the common and not so common causes of sleep deprivation
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes